About

Publications While At HealthPartners

selected publications

Journal Article

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial. 

Age and Ageing. 2019

2017;40:777-83. 

Diabetes care. 2017

Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the Diabetes Control and Complications Trial. 

Diabetes care. 2017

Liraglutide and renal outcomes in type 2 diabetes. 

New England Journal of Medicine. 2017

Liraglutide and cardiovascular outcomes in type 2 diabetes. 

New England Journal of Medicine. 2016

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. 

Diabetes, Obesity & Metabolism. 2015

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. 

Pancreas. 2014

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 

American Heart Journal. 2013

Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. 

Diabetologia. 2011

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. 

Archives of Internal Medicine. 2011

Contact

full name

B. Zinman

Quick Info

 

Collaboration

Co-author network

Map of science